Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

OBJECTIVES: To assess the impact of extra-articular spondyloarthritis (SpA) manifestations (anterior uveitis, psoriasis and inflammatory bowel disease (IBD)), and of comorbidities, on tumour necrosis factor alpha inhibitor (TNFi) drug retention in ankylosing spondylitis (AS). METHODS: We identified...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:RMD Open
Autores principales: Lindström, Ulf, Olofsson, Tor, Wedrén, Sara, Qirjazo, Ilia, Askling, Johan
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2018
Materias:
Spondyloarthritis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6203098/
https://ncbi.nlm.nih.gov/pubmed/30402269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2018-000762
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares